Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: safety and patient-reported outcomes from the monarchE study
2022 · Annals of Oncology · 112 citations
https://doi.org/10.1016/j.annonc.2022.03.006
F
F Boyle
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
5
Papers
320
Citations
5
h-index
4
i10-index
F Boyle is an academic researcher from The University of Sydney. The author has contributed to research in topics: Ethics in Clinical Research & Patient-Provider Communication in Healthcare & Health Systems, Economic Evaluations, Quality of Life. The author has an h-index of 5, co-authored 5 publications.
Papers by this author
worksImproving decision making about clinical trial participation – a randomised controlled trial of a decision aid for women considering participation in the IBIS-II breast cancer prevention trial
2014 · British Journal of Cancer · 86 citations
https://doi.org/10.1038/bjc.2014.144
Overall survival with abemaciclib in early breast cancer
2025 · Annals of Oncology · 9 citations
https://doi.org/10.1016/j.annonc.2025.10.005
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat